Celltrion–MustBio Collaborate on PD-1×VEGF×IL-2v Cancer Therapy Date2025-11-20 View27 https://www.hitnews.co.kr/news/articleView.html?idxno=71167 Prev MB7 Project Selected for the 2025 Cancer Efficacy Evaluation/Consulting Service Program Next There's no next post. back to list
